Literature DB >> 26932206

Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.

M G Sanz1, A Loynachan2, D W Horohov1.   

Abstract

Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge. British Veterinary Association.

Entities:  

Keywords:  Bacterial diseases; Horses; Respiratory disease

Mesh：

Substances：

Year:  2016        PMID： 26932206     DOI： 10.1136/vr.103095

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


  8 in total

Review 1.  Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equi.

Authors:  Sonsiray Álvarez-Narváez; Laura Huber; Steeve Giguère; Kelsey A Hart; Roy D Berghaus; Susan Sanchez; Noah D Cohen
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-14       Impact factor: 11.056

2.  Vaccination of Mice with Virulence-Associated Protein G (VapG) Antigen Confers Partial Protection against Rhodococcus equi Infection through Induced Humoral Immunity.

Authors:  Marcel M Trevisani; Ebert S Hanna; Aline F Oliveira; Silvia A Cardoso; Maria C Roque-Barreira; Sandro G Soares
Journal:  Front Microbiol       Date:  2017-05-11       Impact factor: 5.640

3.  Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi.

Authors:  Colette Cywes-Bentley; Joana N Rocha; Angela I Bordin; Mariana Vinacur; Safia Rehman; Tanweer S Zaidi; Mark Meyer; Sarah Anthony; McKenzie Lambert; Daniel R Vlock; Steeve Giguère; Noah D Cohen; Gerald B Pier
Journal:  PLoS Pathog       Date:  2018-07-19       Impact factor: 6.823

4.  Strain-to-strain variation of Rhodococcus equi growth and biofilm formation in vitro.

Authors:  Adina R Bujold; Nicholas R Lani; Macarena G Sanz
Journal:  BMC Res Notes       Date:  2019-08-19

5.  In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly-N-acetyl glucosamine hyperimmune plasma compared to commercial plasma products.

Authors:  Chelsea N Folmar; Colette Cywes-Bentley; Angela I Bordin; Joana N Rocha; Jocelyne M Bray; Susanne K Kahn; Amanda E Schuckert; Gerald B Pier; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2019-04-29       Impact factor: 3.333

6.  Randomized, controlled trial comparing Rhodococcus equi and poly-N-acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals.

Authors:  Susanne K Kahn; Colette Cywes-Bentley; Glenn P Blodgett; Nathan M Canaday; Carly E Turner-Garcia; Patricia Flores-Ahlschwede; Laurie L Metcalfe; Mark Nevill; Mariana Vinacur; Patrick J Sutter; Sarah C Meyer; Angela I Bordin; Gerald B Pier; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2021-11-05       Impact factor: 3.333

7.  Identification of key genes and pathways using bioinformatics analysis in septic shock children.

Authors:  Junting Yang; Shunwen Zhang; Jie Zhang; Jiangtao Dong; Jiangdong Wu; Le Zhang; Peng Guo; Suyu Tang; Zhengyong Zhao; Hongzhou Wang; Yanheng Zhao; Wanjiang Zhang; Fang Wu
Journal:  Infect Drug Resist       Date:  2018-08-14       Impact factor: 4.003

8.  Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi.

Authors:  Aja B Harvey; Angela I Bordin; Joana N Rocha; Jocelyn M Bray; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2020-12-16       Impact factor: 3.175
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.